Education
About Us
Working with TipRanks
Follow Us
D.N.A Biomedical Solutions Ltd (IL:DNA)
:DNA
DNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range59.00 - 121.80
Previous CloseN/A
Volume74.00K
Average Volume (3M)241.18K
Market Cap
141.64M
Enterprise Value64.71M
Total Cash (Recent Filing)67.33M
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)6.4
Beta0.48
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding123,164,100
10 Day Avg. Volume248,440
30 Day Avg. Volume241,176
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.31
Price to Sales (P/S)0.00
P/FCF Ratio371.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DNA FAQ
What was D.N.A Biomedical Solutions Ltd’s price range in the past 12 months?
D.N.A Biomedical Solutions Ltd lowest stock price was 59.00 and its highest was 121.80 in the past 12 months.
What is D.N.A Biomedical Solutions Ltd’s market cap?
D.N.A Biomedical Solutions Ltd’s market cap is 141.64M.
When is D.N.A Biomedical Solutions Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were D.N.A Biomedical Solutions Ltd’s earnings last quarter?
Currently, no data Available
Is D.N.A Biomedical Solutions Ltd overvalued?
According to Wall Street analysts D.N.A Biomedical Solutions Ltd’s price is currently Overvalued.
Does D.N.A Biomedical Solutions Ltd pay dividends?
D.N.A Biomedical Solutions Ltd does not currently pay dividends.
What is D.N.A Biomedical Solutions Ltd’s EPS estimate?
D.N.A Biomedical Solutions Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does D.N.A Biomedical Solutions Ltd have?
D.N.A Biomedical Solutions Ltd has 123,164,100 shares outstanding.
What happened to D.N.A Biomedical Solutions Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of D.N.A Biomedical Solutions Ltd?
Currently, no hedge funds are holding shares in IL:DNA
Company Description
D.N.A Biomedical Solutions Ltd
Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.